Sharing R&D risk in healthcare via FDA hedges
Year of publication: |
2022
|
---|---|
Authors: | Jørring, Adam ; Lo, Andrew W. ; Philipson, Tomas J. ; Singh, Manita ; Thakor, Richard T. |
Published in: |
The review of corporate finance studies : RCFS. - Oxford : Oxford University Press, ISSN 2046-9136, ZDB-ID 2650556-3. - Vol. 11.2022, 4, p. 880-922
|
Subject: | Pharmakologie | Pharmacology | Forschungskosten | Research expenditure | Arzneimittelrecht | Pharmaceutical law | Genehmigung | Permit | Optionsgeschäft | Option trading | Hedging | Risikomanagement | Risk management | USA | United States |
-
Sharing RD risk in healthcare via FDA hedges
Jørring, Adam, (2017)
-
Sharing R&D risk in healthcare via FDA hedges
Jørring, Adam, (2017)
-
Arbiter of science : institutionalization and status effects in FDA drug review 1990 - 2004
Kim, Jerry W., (2012)
- More ...
-
Sharing RD risk in healthcare via FDA hedges
Jørring, Adam, (2017)
-
Sharing R&D risk in healthcare via FDA hedges
Jørring, Adam, (2017)
-
Sharing R&D Risk in Healthcare via FDA Hedges
Jørring, Adam, (2017)
- More ...